Gastrointestinal adverse events (nausea, vomiting, constipation, diarrhea) scale with dose in the STEP program, and about 4.5% of patients discontinue for GI reasons on 2.4 mg semaglutide (Wilding et al., NEJM 2021)
Tel:13736652831 Address:NO.273 SHANGHAI SOUTH STREET,LUQIAO DISTRICT,ZHEJIANG PROVINCE,CHINA
In 2025, the European Medicines Agency concluded that NAION should be listed as a very rare side effect of semaglutide medications, including Ozempic, Wegovy, and Rybelsus, after reviewing clinical studies, adverse event reports, and post-market safety data
Gastrointestinal Symptoms: The second most frequent category of adverse events involved digestive system effects
Method accuracy was demonstrated by recovery values being within 15% of the nominal concentrations for all QC samples
Theres no reason not to use it